site stats

Coherus market cap

WebAbout Coherus. Leadership Team; Board of Directors; Scientific Advisory Board; Immuno-oncology Scientific Advisory Board; Commercial Advisory Committee; Contact Us; … WebGet the latest Coherus Biosciences Inc (CHRS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …

Coherus BioSciences, Inc. (CHRS) - Market Capitalization Market …

WebApr 11, 2024 · A high-level overview of Coherus BioSciences, Inc. (CHRS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … WebThe global crypto market cap is $1.25T, a 2.17 % increase over the last day. Read More The total crypto market volume over the last 24 hours is $50.34B , which makes a 23.24 % increase. gorman\u0027s hot dogs fordham road https://scanlannursery.com

Coherus Biosciences Stock Price Today (NASDAQ: CHRS) Quote, Market Cap …

WebCoherus BioSciences Inc is a commercial-stage biopharmaceutical company building an innovative immuno-oncology franchise funded with cash generated by its diversified … WebMar 6, 2024 · Coherus BioSciences, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $45.35 million for the quarter ended December 2024, missing the Zacks Consensus... chick\u0027n mix

Coherus BioSciences - Choice Without Compromise

Category:Coherus BioSciences (CHRS) - Earnings

Tags:Coherus market cap

Coherus market cap

Coherus: Biosimilar Specialist With Approval Shot For Cancer Drug

WebCoherus Biosciences Stock Price Today (NASDAQ: CHRS) Quote, Market Cap, Chart WallStreetZen Coherus Biosciences Inc Stock Add to Watchlist Overview Forecast Earnings Dividend Ownership $6.00 +0.10 (+1.69%) Updated Mar 24, 2024 1W - 1.32% 1M - 13.54% 3M + 5.45% 1Y - 53.45% CHRS Price $6.00 Fair Value Price $6.82 Market … WebMar 28, 2024 · On Friday 03/10/2024 the closing price of the Coherus BioSciences Inc share was $6.07 on NAS. Compared to the opening price on Friday 03/10/2024 on NAS of $6.25, this is a drop of 2.97%. Coherus ...

Coherus market cap

Did you know?

WebJun 18, 2024 · CHRS has a market cap of $1.08bn and a cash balance of $399mn. Last year, the company had nearly half a billion dollar in product revenue. Bottom line The standard gripe of investors with CHRS... WebAug 19, 2024 · Coherus’ market cap is US$1 billion, the forward P/E one year is -4.46, the EPS is US$-2.32, and the 52-week highest and the lowest stock price of the company was US$22.22 and US$12.21. The stock fell 18.64 percent YTD. Also read: Check out these fastest-growing small-cap healthcare stocks

WebApr 6, 2024 · Sentiment All Sentiments. Source. Headline. Coherus BioSciences (NASDAQ:CHRS) Coverage Initiated by Analysts at StockNews.com. americanbankingnews.com - March 20 at 7:20 AM. Coherus BioSciences (NASDAQ:CHRS) Price Target Raised to $23.00. americanbankingnews.com - March 17 … WebApr 9, 2024 · The stock has a market cap of $609.81 million, a P/E ratio of -2.04 and a beta of 0.95. Coherus BioSciences, Inc. has a 1-year low of $5.58 and a 1-year high of $14.11.

WebApr 12, 2024 · According to analysts' consensus price target of $16.50, Coherus BioSciences has a forecasted upside of 120.9% from its current price of $7.47. Amount of Analyst Coverage Coherus BioSciences has … WebApr 12, 2024 · The average twelve-month price prediction for Coherus BioSciences is $16.50 with a high price target of $26.00 and a low price target of $11.00. Do Wall Street analysts like Coherus BioSciences more than its competitors? Analysts like Coherus BioSciences more than other Medical companies.

WebCoherus BioSciences market cap history and chart from 2013 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the …

WebAbout Coherus Immuno-oncology Dedicated to Improving Patient Lives by Expanding Access to Life-Changing Biologic Medicines Our approved products span multiple therapeutic areas including oncology, … chick\u0027s agway southoldWebMar 28, 2024 · The Coherus BioSciences stock price gained 7.00% on the last trading day (Tuesday, 28th Mar 2024), rising from $6.00 to $6.42.During the last trading day the stock fluctuated 4.30% from a day low at $6.28 to a day high of $6.55.The price has risen in 5 of the last 10 days and is up by 1.1% over the past 2 weeks. Volume has increased on the … chick\u0027n fun wesley chapel flWebApr 10, 2024 · Coherus BioSciences stock price target raised to $11 from $7 at UBS Sep. 16, 2024 at 8:45 a.m. ET by Tomi Kilgore Coherus BioSciences started at neutral with … gorman\u0027s kitchen \u0026 bath galleryWebNov 8, 2024 · We ended the quarter with cash, cash equivalents and marketable securities of $468.7 million compared to a balance of $454.5 million at June 30, 2024. We are … chick\u0027n riceWebApr 12, 2024 · Coherus BioSciences (NASDAQ:CHRS – Get Rating) and Sutro Biopharma (NASDAQ:STRO – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, dividends, analyst recommendations, risk, valuation and … gorman\\u0027s heating and coolingWebDec 20, 2024 · Coherus markets UDENYCA® (pegfilgrastim-cbqv), a biosimilar of Neulasta® in the United States, and expects to launch the FDA-approved Humira® biosimilar YUSIMRY™ (adalimumab-aqvh) in the ... chick\u0027n rice san joseWebMarket Cap $609.81 M Shares Outstanding 79.61 M Public Float 74.39 M Yield CHRS is not currently paying a regular dividend. Latest Dividend N/A Ex-Dividend Date N/A Short … chick\u0027n headz fayetteville ar